What question did this study set out to answer?

The aim is to develop a framework that evaluates synthetic clinical data's fidelity, privacy risk, and diagnostic utility in severely imbalanced settings.

June 27, 2026BMC Medical Informatics and Decision MakingOpen Access

An integrated evaluation framework for synthetic clinical data in severely imbalanced settings: fidelity, privacy-risk profiling, and diagnostic utility

View Full Paper

Ask AI

Bookmark

Authors

YKYoungtae KimYonsei University JLJungwoo LeeYonsei University SKSang Baek KohYonsei University

Discussion

Member takes

Implication

Randomized trial evaluates diagnostic utility and privacy risks of synthetic data in rare disease contexts, highlighting critical validation needs.

Key Points

The aim is to develop a framework that evaluates synthetic clinical data's fidelity, privacy risk, and diagnostic utility in severely imbalanced settings.
Developed an integrated evaluation framework for variational autoencoders and conditional GANs.
Used structured electronic health record data with disease prevalence of 0.8% to 7.5%.
Employed distance-based metrics and minority-class-sensitive classifiers like XGBoost and random forest.
Correlation similarity between empirical and synthetic data was 0.794 for VAE and 0.667 for CTGAN.
CTGAN-trained classifiers achieved non-zero recall for the rare outcome (0.8% prevalence) at the cost of overall accuracy.
Membership inference attack performance remained near random guessing, indicating potential privacy concerns.

Cite This Study

Kim et al. (2026) studied this question.

synapsesocial.com/papers/6a3f6817aea7db3c1953f4f1 https://doi.org/10.1186/s12911-026-03648-1

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial evaluates diagnostic utility and privacy risks of synthetic data in rare disease contexts, highlighting critical validation needs.

An integrated evaluation framework for synthetic clinical data in severely imbalanced settings: fidelity, privacy-risk profiling, and diagnostic utility

Discussion

Member takes

Implication

Key Points

Cite This Study

An integrated evaluation framework for synthetic clinical data in severely imbalanced settings: fidelity, privacy-risk profiling, and diagnostic utility

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider